A Common Condition That Often Goes Unrecognized
Lichen sclerosus is a chronic inflammatory skin condition that most commonly affects the genital area, particularly in postmenopausal women. It causes characteristic skin changes, itching, pain, and — without treatment — progressive scarring that can permanently alter genital anatomy and function.
Despite affecting an estimated 1 in 70 women at some point in their lives, lichen sclerosus is frequently misdiagnosed or undiagnosed. Symptoms get attributed to recurrent yeast infections, vaginal atrophy, or simply dismissed as a natural part of aging. The right diagnosis matters because effective treatment exists, untreated disease causes lasting damage, and there is a small but real associated cancer risk.
At Zimmer Medical Group, we evaluate persistent vulvar symptoms thoroughly and treat lichen sclerosus appropriately when found.
What Lichen Sclerosus Is
Lichen sclerosus is an autoimmune-mediated chronic inflammatory condition that affects the skin and mucous membranes. While it can occur anywhere on the body, the vast majority of cases involve the anogenital region:
- Vulva and surrounding skin in women
- Glans and prepuce in men
- Less commonly, perianal area, breast, axilla, back
The condition is much more common in women than men (roughly 6:1) and has two age peaks — premenopausal women (sometimes children) and postmenopausal women.
Recognizing the Symptoms
Common Symptoms
- Persistent vulvar or perianal itching, often severe
- Burning, soreness
- Pain with intercourse (dyspareunia)
- Pain with urination or bowel movements
- Tearing of fragile skin with minor friction
- Bleeding from skin tears
Visible Changes
- White, atrophic, parchment-like skin patches
- "Cigarette paper" or "porcelain-like" appearance
- Loss of normal anatomic landmarks (labia minora, clitoral hood)
- Fissures, ulcers
- Bruising-like discoloration in affected areas
- Architectural changes — fusion of labia, narrowing of vaginal opening
- Sometimes thickened, hyperpigmented patches in chronic disease
What Patients Sometimes Notice First
- Inability to fully retract the clitoral hood
- Sensation that the vagina has become tighter
- Tearing during intercourse that seemed minor in the past
- Persistent itching despite treatment for yeast
- Pain wiping after using the bathroom
Why It's Underdiagnosed
Several factors contribute:
- Patients embarrassed to discuss genital symptoms
- Self-treatment with over-the-counter yeast medications without seeking evaluation
- Symptoms attributed to vaginal atrophy from menopause
- Brief gynecologic exams that don't carefully inspect the vulva
- Lack of physician awareness about the condition
- Failure to biopsy when characteristic features are present
Many patients have symptoms for years before receiving the correct diagnosis.
What Lichen Sclerosus Is Not
Lichen sclerosus is sometimes confused with:
- Vaginal atrophy from menopause — affects the vagina, not skin; responds to estrogen; doesn't cause architectural changes
- Yeast infections — usually short-lived, respond to antifungals
- Lichen planus — different inflammatory pattern, can affect mouth and other sites
- Vulvar dermatitis — irritant or allergic
- Vulvodynia — pain without visible changes
- Vulvar cancer or precancerous lesions — must be ruled out, sometimes coexist
Diagnosis
Clinical Diagnosis
Often the diagnosis can be made by visual inspection by a clinician familiar with the condition. Key features:
- Distribution (figure-of-8 pattern around vulva and anus is classic)
- White, atrophic appearance
- Loss of architecture
- Fissures or signs of trauma
Biopsy
Biopsy is recommended in many cases:
- To confirm diagnosis when uncertain
- To rule out vulvar intraepithelial neoplasia or cancer
- For atypical features
- For treatment-resistant disease
A small punch biopsy can be done in the office under local anesthesia.
Associated Conditions
Lichen sclerosus can be associated with other autoimmune conditions:
- Hashimoto's thyroiditis — present in 10–20 percent
- Vitiligo
- Pernicious anemia
- Type 1 diabetes
- Alopecia areata
Screening for associated autoimmune disease is reasonable when lichen sclerosus is diagnosed.
Treatment
High-Potency Topical Corticosteroids
The cornerstone of treatment:
- Clobetasol propionate 0.05% is the standard
- Applied to affected areas once daily for several weeks, then tapered
- Long-term maintenance often needed (1–3 times weekly)
- Far more effective than mid- or low-potency steroids
- Skin atrophy from steroid is uncommon when used appropriately on already-atrophic genital skin
The historical fear of using high-potency steroids on the vulva has caused many patients to be undertreated. Current evidence strongly supports clobetasol as first-line.
Calcineurin Inhibitors
Topical tacrolimus (Protopic) or pimecrolimus (Elidel):
- Useful as steroid-sparing agents
- Particularly helpful for maintenance after initial control
- Generally well-tolerated; can cause initial burning
Other Considerations
- Avoid irritants: scented soaps, douches, bubble baths, harsh wipes, tight synthetic underwear
- Treat associated conditions: vaginal atrophy, lichen planus, infections
- Address pain with intercourse: vaginal moisturizers, lubricants, sometimes topical estrogen, dilators if narrowing has occurred
- Manage chronic pain if present
- Pelvic floor physical therapy for selected patients with muscle involvement
Surgical Treatment
Reserved for:
- Complications like severe scarring affecting urination
- Significant labial fusion
- Removal of suspicious lesions
- Treatment of cancer if it develops
The Cancer Risk
Patients with lichen sclerosus have a roughly 4–5 percent lifetime risk of developing vulvar squamous cell carcinoma — substantially higher than the general population (about 0.1 percent). The risk:
- Is most pronounced in patients with longstanding, undertreated disease
- Decreases with effective treatment
- Warrants regular surveillance
- Particularly concerns lesions that change, develop new thickening, ulcerate, or fail to respond to treatment
This is one of the most important reasons treatment matters even when symptoms are tolerable. Effective treatment reduces both symptoms and cancer risk.
Long-Term Management
Lichen sclerosus is a chronic condition. Long-term management includes:
- Maintenance topical therapy (typically reduced frequency)
- Regular follow-up exams every 6–12 months
- Patient education on what to watch for
- Prompt evaluation of new lesions or symptoms
- Annual examination of vulva
- Biopsy of suspicious or non-responsive areas
With consistent treatment, most patients achieve symptomatic control and prevent disease progression.
Considerations for Younger Patients
Lichen sclerosus also occurs in:
- Premenopausal women
- Children (often resolves at puberty)
- Pregnant patients (treatment continues during pregnancy with appropriate steroid choice)
These groups deserve the same careful diagnosis and treatment as postmenopausal patients.
What Patients Should Know
- Persistent vulvar itching is not normal and deserves evaluation
- Repeated yeast treatments without examination is a missed opportunity
- Lichen sclerosus is treatable, not curable
- Long-term steroid use on the vulva is appropriate when supervised
- Untreated disease causes lasting damage
- Cancer risk, while small, is real and reduced with treatment
- Sexual function can be preserved with timely treatment
When to See Your Doctor
- Persistent vulvar itching, burning, or soreness
- Pain with intercourse
- Genital skin changes
- Bleeding or tearing of vulvar skin
- Architectural changes you've noticed
- Recurrent "yeast infections" that aren't responding
- Following menopause with new vulvar symptoms
- Family history of lichen sclerosus or autoimmune disease
The International Society for the Study of Vulvovaginal Disease and the American College of Obstetricians and Gynecologists provide additional clinical resources.
Persistent vulvar symptoms that haven't been adequately diagnosed or treated? Contact Zimmer Medical Group for a thorough evaluation that considers lichen sclerosus and effective treatment when found.
